MUC1 and neoplasm: confirmed that expression of secretory mucin 1 (MUC1/sec) in breast tumor cells can initiate T cell-dependent immune rejection responses and promote the recruitment of immune cells by increasing chemokine CCL2 secretion, aiding in anti-tumor therapy (97).